Showing results (1-10 of 421) with videos related to

Sort By:
Pageof 43
Human Gene Therapy|January 1, 1995
A phase I trial of B7-transfected or parental lethally irradiated allogeneic melanoma cell lines to induce cell-mediated immunity against tumor-associated antigen presented by HLA-A2 or HLA-A1 in patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol 9401R T Fenton, M Sznol, D G Luster, et al.
Seminars in Oncology|April 1, 1997
Antigen-specific agents in developmentM Sznol, J Holmlund
Current Opinion in Oncology|September 1, 1996
Immunotherapy for non-Hodgkin's lymphomaD L Longo
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Chemotherapy alone in the treatment of patients with early stage Hodgkin's diseaseD L Longo
Current Opinion in Hematology|July 1, 1994
Non-Hodgkin's lymphomaD L Longo
Hematology/Oncology Clinics of North America|October 1, 1991
Biologic agents and approaches in the management of patients with lymphoma. A critical appraisalD L Longo
Oncology (Williston Park, N.Y.)|June 1, 1994
Clinical applications of IL-2M Sznol, D R Parkinson
Cancer Research|May 15, 1990
Phase I and immunomodulatory study of a muramyl peptide, muramyl tripeptide phosphatidylethanolamineW J Urba, L C Hartmann, D L Longo, et al.
Blood|October 1, 1991
Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2aJ W Smith, D L Longo, W J Urba, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Dose-related immunologic effects of levamisole in patients with cancerJ Janik, W C Kopp, J W Smith, et al.
Pageof 43